Ignatia amara
- Manufacturer
- Boiron | Boiron, Inc.
- Effective date
- 2025-10-23
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 4
- Source
- full-release
- Hydrated at
- 2026-06-01 02:37:12
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active ingredient** (in each pellet)
Ignatia amara 30C HPUS (0.44 mg)
Less than 10 -12 mg strychnine alkaloids per pellet
The letters "HPUS" indicate that the components in this product are officially monographed in the Homeopathic Pharmacopoeia of the United States.
OTC - PURPOSE SECTION
Ignatia amara 30C HPUS .... Relieves apprehension, hypersensitivity to stress
INDICATIONS & USAGE SECTION
Uses*
temporarily relieves symptoms associated with occasional nervous tension such as:
- hypersensitivity
- apprehension
- irritability
- grief of sadness
- moodiness
- lump in throat
- nervous yawning
OTC - STOP USE SECTION
Stop use and ask a doctor if symptoms persist for more than 3 days or worsen.
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. In case of accidental overdose, get medical help or contact a Poison Control Center right away.
DOSAGE & ADMINISTRATION SECTION
- Adults and children 12 years of age and older: At the onset of symptoms, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor.
- Children under 12 years of age: Ask a doctor.
INACTIVE INGREDIENT SECTION
lactose, sucrose
OTC - QUESTIONS SECTION
BoironUSA.com Info@boiron.com
1-800-BOIRON-1 (1-800-264-7661)
Made in France
Distributed by Boiron, Inc.
Newtown Square, PA 19073
SPL UNCLASSIFIED SECTION
- do not use if glued carton end flaps are open or if pellet dispenser seal is broken
- contains 0.25 g of sugar per dose
- retain carton for full drug facts
EMOTIONAL STRESS RELIEF*
Hypersensitivity Grieving Irritability Moodiness*
No known drug interactions
1 Tube
3 Tubes
APPROX. 80 PELLETS EACH
TOTAL 240 PELLETS
Turn tube upside down
Twist until 5 pellets are dispensed
Remove cap and pour pellets under the tongue
*CLAIMS BASED ON TRADITIONAL HOMEOPATHIC PRACTICE NOT ACCEPTED MEDICAL EVIDENCE. NOT FDA EVALUATED.
*C,K,CK, and X are homeopathic dilutions: see BoironUSA.com/info for details.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0220-2598-41 | Ignatia amara | 30 [hp_C] in 1 TUBE | PELLET | 30 | 4 | |
| 0220-2598-43 | Ignatia amara | 3 in 1 BOX | PELLET | 3 | 4 | |
| 0220-2598-43 | Ignatia amara | 30 [hp_C] in 1 TUBE | PELLET | 30 | 4 |
Products#
Every source-derived product name is available through these pages.
- Ignatia amara
- STRYCHNOS IGNATII SEED
- LACTOSE, UNSPECIFIED FORM
- ANHYDROUS LACTOSE
- SUCROSE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 0220-2598 | 0220-2598-41, 0220-2598-43 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| STRYCHNOS IGNATII SEED | 1NM3M2487K | ACTIB |
| LACTOSE, UNSPECIFIED FORM | J2B2A4N98G | IACT |
| SUCROSE | C151H8M554 | IACT |
Source Document#
Older Hydrated Versions#
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 3 | 2023-01-23 | full-release | 2026-06-01 02:19:51 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ignatia amara | STRYCHNOS IGNATII SEED | Boiron | 85cb8bb9-df5c-d137-e053-2a91aa0a7360 | 2025-10-23 | 0220-2598-41 0220-2598-43 0220-2598 00220259843 00220259841 41d71fd3-48db-a69a-e063-6394a90a7371 85cb8bb9-df5c-d137-e053-2a91aa0a7360 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.





